Testing a new blood test for endometrial cancer screening
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is testing whether a blood test that looks at small molecules (metabolites) can help find endometrial cancer early in post-menopausal women. If you are between 50 and 80 years old and have not had a hysterectomy or certain hormone treatments, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 50 and 80 years old.
- You have gone through menopause (no longer having menstrual periods).
- You have not had your uterus removed (hysterectomy).
- You are not currently using hormone replacement therapy (HRT).
- You are not taking medications that suppress your immune system (immunosuppressive therapy).
- You are willing to sign a consent form to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This trial tests whether DNA changes in urine, vaginal, or cervical samples can help find endometrial cancer earlier in women with postmenopausal bleeding. If you are having tests for this bleeding, your samples could help improve detection.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This Phase 2 study checks whether a new lab test (using samples from your body) can detect signs specific to endometriosis. It may help improve how endometriosis is identified, especially when people are heading toward laparoscopic surgery.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
This study tests two less invasive methods—sampling cells from the lining of the uterus (endometrial cytology) and checking DNA changes in the cervix—to see if they can help detect endometrial cancer or atypical hyperplasia, and to monitor response in people who are preserving their fertility. It aims to find a gentler alternative to traditional biopsy.
Hear when a new Endometrial Carcinoma (EC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.